PhRMA v. Maine
Executive Summary
Supreme Court requests brief from U.S. Solicitor General Theodore Olson before deciding whether to hear the Pharmaceutical Research & Manufacturers of America's case against the Maine drug discount program. Sen. Olympia Snowe (R-Maine) asks Olson in an Oct. 10 letter to request that the court not review the case, which would allow Maine to proceed with implementation of the program (1"The Pink Sheet" July 9, p. 3)
You may also be interested in...
AARP Eyeing AWP Lawsuits After Joining Generic Competition Cases
AARP's next area for pharmaceutical litigation may be joining state lawsuits regarding reporting of average wholesale prices
AARP Eyeing AWP Lawsuits After Joining Generic Competition Cases
AARP's next area for pharmaceutical litigation may be joining state lawsuits regarding reporting of average wholesale prices
Maine Medicaid Waiver Qualifies For Rx Rebates By State Contributions – Court
Maine's Medicaid waiver program qualifies for manufacturer rebates because of the state's contribution to beneficiaries' prescription costs, the D.C. federal court decided Feb. 25